Correlation of Aminoglycoside and Vancomycin Pharmacokinetic Parameters

Abstract

OBJECTIVE:

To investigate a correlation between the elimination rate constants (K_e) of aminoglycosides (AG) and vancomycin; to investigate the correlation between actual K_e and creatinine clearance (Cl_cr) for AG versus vancomycin; to investigate the calculated versus actual K_e for AG and vancomycin; and to investigate a correlation between volumes of distribution (V_d) between AG and vancomycin.

DESIGN:

Retrospective data collection.

METHODS:

Patients in our institution who received AGs or vancomycin concomitantly or within six weeks of each other were identified retrospectively. Patient subpopulations were identified and analyzed collectively as well as individually. Steady-state serum concentrations of AG and vancomycin (more than four half-lives) were obtained and kinetic parameters (K_e‘ V_d) were calculated using first-order pharmacokinetic equations. Linear regression was used to determine correlation coefficients.

RESULTS:

In the total population and all subpopulations, the correlation between K_e of AG and vancomycin was superior to the correlation between K_e and Cl_cr. The correlations (r²) between K_e for AG and vancomycin in the total, general medicine, oncology, and intensive care units (ICU) populations were 0.572, 0.878, 0.349, and 0.561, respectively. The correlations (r²) between K_e and Cl_cr for AG in the total, general medicine, oncology, and ICU populations were 0.235, 0.430, 0.005, and 0.238, respectively. The correlations (r²) between K_e and Cl_cr for vancomycin in the total, general medicine, oncology, and ICU populations were 0.300, 0.407, 0.055, and 0.309, respectively.

CONCLUSIONS:

The correlation between K_e of AG and vancomycin may be beneficial for predicting K_e of vancomycin when AG concentrations have already been obtained or vice versa, and may give more accurate estimations of dosing intervals and require less time adjusting, ordering, and interpreting concentrations and dosages.

Get full access to this article

View all access options for this article.

References

Matzke

McGory

Halstenson

Keane

. Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother 1984; 25: 433–7.

Lee

Anderson

Chen

. Vancomycin, a new antibiotic. V. Distribution, excretion and renal clearance. Antibiotic Annu 1956–57: 82–9.

Cunha

Quintiliani

Deglin

Izard

Nightingale

. Pharmacokinetics of vancomycin in anuria. Rev Infect Dis 1981; 3: S269–72.

Rotschafer

Crossley

Zaske

Mead

Sawchuk

Solem

. Pharmacokinetics of vancomycin; observations in 28 patients and dosage recommendations. Antimicrob Agents Chemother 1982; 22: 391–4.

Brown

DHW

Fong

Bogerd

Maksymiuk

Bolivar

Effects of hepatic function on vancomycin clinical pharmacology. Antimicrob Agents Chemother 1983; 23: 603–9.

Cockcroft

Gault

. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41.

Sawchuk

Zaske

Cipolle

Wargin

Strate

. Kinetic models for gentamicin dosing with the use of individual patient parameters. Clin Pharmacol Ther 1977; 21: 360–9.

Zaske

Cipolle

Rotschafer

Solem

Mosier

Strate

. Gentamicin pharmacokinetics in 1640 patients: method for control of serum concentrations. Antimicrob Agents Chemother 1982; 21: 407–11.

Hull

Sarubbi

. Gentamicin serum concentrations: pharmacokinetic predictions. Ann Intern Med 1976; 85: 183–9.

10.

Friedman

Norman

Yoshikawa

. Correlation estimated renal function parameters versus 24-hour creatinine clearance in ambulatory elderly. J Am Geriatr Soc 1989; 37: 145–9.

11.

Durakovic

. Creatinine clearance in the elderly: a comparison of direct measurement and calculation from serum creatinine. Nephron 1986; 44: 66–9.

12.

Bauer

Brooks

Burch

. Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am J Kidney Dis 1982; 2: 337–46.

13.

Bertino

Booker

Franck

Rybick

. Gentamicin pharmacokinetics in patients with malignancies. Antimicrob Agents Chemother 1991; 35: 1501–3.

14.

Etzel

Nafziger

Bertino

. Variation in the pharmacokinetics of gentamicin and tobramycin in patients with pleural effusions and hypoalbuminemia. Antimicrob Agents Chemother 1992; 36: 679–81.

15.

Freeman

Quintiliani

Nightingale

. Vancomycin therapeutic drug monitoring: Is it necessary? Ann Pharmacother 1993; 27: 594–8.

16.

Ackerman

Vannier

Eudy

. Analysis of vancomycin time-kill studies with staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response. Antimicrob Agents Chemother 1992; 36: 1766–9.